shokat mutation presentation

20
Shokat Mutation Akanksha Singh & Chloe Chabanon-Hicks

Upload: allshewrote

Post on 07-Nov-2014

129 views

Category:

Documents


3 download

DESCRIPTION

PPT

TRANSCRIPT

Page 1: Shokat Mutation Presentation

Shokat Mutation

Akanksha Singh & Chloe Chabanon-Hicks

Page 2: Shokat Mutation Presentation

Kinases in Action!

Page 3: Shokat Mutation Presentation

Amplification

Page 4: Shokat Mutation Presentation

The Spark of Kinase Research

The Cori’s (1930)

Page 5: Shokat Mutation Presentation

1st Observation of Phosphorylation Event

Eugene P. Kennedy (1954)

Page 6: Shokat Mutation Presentation

Kinase Transfer of y-Phosphate to Substrate

Edmund and Fisher ( 1959)

Page 7: Shokat Mutation Presentation

The Big Question

Past Methods:

Disrupting enzyme 3 and observe corresponding phenotype.

BUT …

Enzyme 3 is affected by enzymes 1&2 and affects enzyme 4, the result of disrupting the gene coding for enzyme 3 may generate the same phenotype as disrupting the gene that encodes for enzymes 1,2,or 4. THEN, specific kinase function could not be

Verified because kinase disruption was not reversible

If we wanted to study the role of kinase 3…

Page 8: Shokat Mutation Presentation

Kevan Shokat 2000

“I kept asking him, ‘How does this experiment tell you which kinase is involved? There’s some missing tool here. We need a better way of telling which precise kinase is working”.

Page 9: Shokat Mutation Presentation

Exploitation of the Conserved ATP Binding Cassette

The Shokat mutation works by mutating the single active site residue in the ATP binding site of a kinase to a less bulky amino acid like glycine, known as the “gatekeeper residue”

Page 10: Shokat Mutation Presentation

Identifying the Kinase of InterestThis mutation creates a deeper pocket to accept the corresponding artificially created substrate ATP analog

Page 11: Shokat Mutation Presentation

What You Would Expect to Find in the ATP Binding Site…

Page 12: Shokat Mutation Presentation

BUT INSTEAD…

Page 13: Shokat Mutation Presentation

AS SEEN ON ATP Inhibitor Analogs Analogs can not phosphorylate substrates

Page 14: Shokat Mutation Presentation

Identifying Substrates of InterestAn inhibitory molecule is engineered with a bump, interacting with a higher affinity to the modified kinase ATP binding site than ATP, thus preventing kinase activity.

Page 15: Shokat Mutation Presentation

Two Methods: [γ-32P]-labeled ATP analog,

autoradiography

mass spectrometry

Contains a N6-(benzyl) group creating a “binding bump”

Page 16: Shokat Mutation Presentation

ATP analog engineered with phosphorothiolate (PO3S–)

Substrae

PO3S–

Substrae

PO3S–

Substrae

PO3S–

Substrae

PO3S–

Immunoprecipation

Page 17: Shokat Mutation Presentation

Observation of Kinase- Substrate Localization

Antibodies with fluorescent tags

Anti-Breast Tumor Kinase antibody

Page 18: Shokat Mutation Presentation

What the Kinase Sequence Database has to offer…

currently contains 7,128 protein kinases, observed from 948 different organisms.

Page 19: Shokat Mutation Presentation
Page 20: Shokat Mutation Presentation

FLASH CARDThe Shokat mutation works by mutating the single active site residue in the ATP binding site of a kinase to a less bulky amino acid like glycine, known as the “gatekeeper residue”